Linkana vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Brazilian supplier qualification and SRM platform serving Ambev, BASF, and Nubank; $1.7M ARR competing with SAP Ariba for LatAm procurement teams with built-in Brazilian regulatory compliance.
About
Linkana is a Brazilian supplier relationship management (SRM) platform that automates supplier qualification, onboarding, and risk monitoring for procurement teams at large Latin American companies — replacing the manual, paper-based supplier approval processes that require weeks and significant staff time at enterprises like Ambev, BASF, Nubank, and Nivea, which are current customers. Founded in 2019 in São Paulo and a Y Combinator graduate backed by YC, Latitud, and Google for Startups with $261,000 raised, Linkana reached $1.7 million in annual revenue in 2024 with a 24-person team.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.